CAS RN: 206278-26-4
2-Fluoro-3-iodopyrazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251001
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 206278-26-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
206278-26-4 / 2-fluoro-3-iodopyrazine
Standard CAS: 206278-26-4
Multi CAS: No
Basic Information
copy
CAS
206278-26-4 copy
Multi CAS
No copy
Molecular Formula
C4H2FIN2 copy
Molecular Weight
223.970000 copy
Exact Mass
223.924670 copy
SMILES
C1=CN=C(C(=N1)F)I copy
InChI
InChI=1S/C4H2FIN2/c5-3-4(6)8-2-1-7-3/h1-2H copy
InChIKey
ZGDOFCZYQIJHRG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
8 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
2 copy
Molar refractivity
34.71 copy
TPSA
25.78 copy
LogP / Solubility
WLOGP
1.22 copy
MLOGP
1.08 copy
XLogP3
0.9 copy
Consensus LogP
1.07 copy
Log S (ESOL)
-2.55 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.28 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.13 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.22 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy